• Home
  • Approach To Consun
    Company profile Management team Business Structure
  • Product Center
    Products Introduction Product video Nephrology series Imaging Series Women & Children Series Orthopedics Series Dermatology Series Hepatobiliary Series Gastroenterology Series Tonic Series Other Products
  • R&D Innovation
    R&D Platform R&D Team R&D Technology R&D Achievements
  • Investor Relations
    Corporate Governance Announcements & Circulars Regular Reports Documents available for inspection IR Contact
  • 中文
Investor Relations
  • Corporate Governance
  • Announcements & Circulars
  • Regular Reports
  • Documents available for inspection
  • IR Contact

Announcements & Circulars

  • 2024-05-07 Notification Letter to Non-Registered Shareholders and Reply Form
  • 2024-05-07 Notification Letter to Registered Shareholders and Reply Form
  • 2024-05-07 2024 Share Option Scheme
  • 2024-05-07 FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING
  • 2024-05-07 NOTICE OF EXTRAORDINARY GENERAL MEETING
  • 2024-05-07 (1) PROPOSED ADOPTION OF 2024 SHARE OPTION SCHEME, (2) PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND (3)
  • 2024-04-30 Monthly Return on Movements in Securities for the Month Ended 30 April 2024
  • 2024-04-30 Notification Letter to Non-Registered Shareholders and Reply Form
  • 2024-04-30 Notification Letter to Registered Shareholders and Reply Form
  • 2024-04-30 FORM OF PROXY FOR THE ANNUAL GENERAL MEETING
HomePrevious345678910111213...69NextLast
  • Approach To Consun

    • Company profile
    • Management team
    • Business Structure
  • Product Center

    • Products Introduction
    • Product video
    • Nephrology series
    • Imaging Series
    • Women & Children Series
    • Orthopedics Series
    • Dermatology Series
    • Hepatobiliary Series
    • Gastroenterology Series
    • Tonic Series
    • Other Products
  • R&D Innovation

    • R&D Platform
    • R&D Team
    • R&D Technology
    • R&D Achievements
  • Investor Relations

    • Corporate Governance
    • Announcements & Circulars
    • Regular Reports
    • Documents available for inspection
    • IR Contact

400-930-1681

总机:(86)20-82016888

service@chinaconsun.com

71 Dongpeng Avenue, Huangpu District, Guangzhou

  • Consun

  • Health Station

  • Micro mall

工商红盾标志

Friendship Link: State Food and Drug Administration Inner Mongolia Food and Drug Administration Guangdong Food and Drug Administration Guangxi Food and Drug Administration

粤ICP备15001491号Design: uweb